BioSpace News Archive

Business

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Sonoma Pharmaceuticals, Inc. today announced that it has entered into a distribution agreement with Daewoong Pharmaceutical Co., Ltd. for the marketing and distribution of Primocyn TM Skin Solution products.

January 31, 2023
·
4 min read
Pharm Country

Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization

Sharps Technology, Inc. announces the first shipments of product from its wholly owned manufacturing facility in Hungary to Nephron Pharmaceuticals to advance the Company’s first commercial operations.

January 31, 2023
·
4 min read
Pharm Country

INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine Candidates

INOVIO announced a strategic reorganization that is intended to deliver on commitments to operational efficiency and better position the company to bring the promise of DNA medicines to patients.

January 31, 2023
·
5 min read
Business

Mirion Technologies Announces Earnings Release and Conference Call Date for Fourth Quarter and Fiscal Year 2022 Results

Mirion Technologies, Inc. announced that it will release its financial results for the fourth quarter and fiscal year 2022 on Tuesday, February 14, 2023.

January 31, 2023
·
1 min read
Business

X-Chem and Kymera Expand Existing Partnership

X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the expansion of its collaboration with Kymera Therapeutics, Inc.

January 31, 2023
·
3 min read
Business

WaterIQ Technologies Forms Scientific Advisory Board

WaterIQ Technologies ™, the leader in next-generation ultrasonic solutions to combat harmful algae and biofilm without the use of chemicals, today announced the addition of three members to its newly formed Scientific Advisory Board.

January 31, 2023
·
5 min read
Business

Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections

Beckman Coulter Diagnostics announced today a strategic partnership to jointly develop and commercialize the proven MeMed BV® test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analyzers.

January 31, 2023
·
5 min read
BioCapital

Thymosin Beta 4 Research Leads Toward Potential Future Anti-aging Therapy

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx” or “Company”), a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today a new scientific publication describing Thymosin beta 4’s (Tβ4) potential as an anti-aging therapy.

January 31, 2023
·
3 min read
Drug Development

Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis

Arcturus Therapeutics Holdings Inc. today announced that the Clinical Trial Application (CTA) for ARCT-032, an inhaled investigational mRNA medicine to treat cystic fibrosis (CF), received approval to proceed into a Phase 1 First-in-Human study in New Zealand.

January 31, 2023
·
5 min read
Biotech Beach

ChromaDex Shares Promising Findings from a Clinical Study Showcasing Combined Metabolic Activators (CMAs), Featuring Nicotinamide Riboside (NR), Improved Cognitive Functions in Alzheimer’s Disease (AD) Patients

ChromaDex Corp. announced promising findings from a first-of-its kind clinical study, as reported in the peer-reviewed journal Translational Neurodegeneration by a team of scientists led by Dr. Adil Mardinoglu.

January 31, 2023
·
7 min read